These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 704704)
21. [Severe cerebellar lesions caused by diphenylhydantoin--a contribution to the problem of hydantoin poisoning]. Krüger H Z Arztl Fortbild (Jena); 1978 Oct; 72(19):944-7. PubMed ID: 726532 [No Abstract] [Full Text] [Related]
27. Phenytoin-induced choreoathetosis in patients with severe myoclonic epilepsy in infancy. Saito Y; Oguni H; Awaya Y; Hayashi K; Osawa M Neuropediatrics; 2001 Oct; 32(5):231-5. PubMed ID: 11748493 [TBL] [Abstract][Full Text] [Related]
28. Influence of bioavailability on the calculated Michaelis-Menten parameters of phenytoin in children. Koren G; Brand N; MacLeod SM Ther Drug Monit; 1984; 6(1):11-4. PubMed ID: 6710554 [TBL] [Abstract][Full Text] [Related]
29. Serum concentrations of free diphenylhydantoin and their relationship to clinical intoxication. Booker HE; Darcey B Epilepsia; 1973 Jun; 14(2):177-84. PubMed ID: 4515987 [No Abstract] [Full Text] [Related]
30. Choreoathetosis during phenytoin treatment. Rasmussen S; Kristensen M Acta Med Scand; 1977; 201(3):239-41. PubMed ID: 403743 [TBL] [Abstract][Full Text] [Related]
31. [Chronic phenytoin intoxication occurred below the toxic concentration in serum and its pathological findings]. Abe H; Yagishita S No To Shinkei; 1991 Jan; 43(1):89-94. PubMed ID: 2054229 [TBL] [Abstract][Full Text] [Related]
33. Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data. Battino D; Croci D; Mamoli D; Messina S; Perucca E Epilepsy Res; 2004; 59(2-3):155-65. PubMed ID: 15246117 [TBL] [Abstract][Full Text] [Related]
34. Chronotherapeutic dose schedule of phenytoin and carbamazepine in epileptic patients. Yegnanarayan R; Mahesh SD; Sangle S Chronobiol Int; 2006; 23(5):1035-46. PubMed ID: 17050216 [TBL] [Abstract][Full Text] [Related]
35. Predictability of unbound antiepileptic drug concentrations in children treated with valproic acid and phenytoin. Miles MV; Snead OC; Thorn MD Clin Pharm; 1988 Sep; 7(9):688-93. PubMed ID: 3149223 [No Abstract] [Full Text] [Related]
36. Fluctuations of plasma phenytoin levels on single dose and twice daily dose regimes. Vajda FJ; Merory J; Bladin PF Proc Aust Assoc Neurol; 1975; 12():61-4. PubMed ID: 1215397 [TBL] [Abstract][Full Text] [Related]
37. [A case of childhood choreoathetosis induced by diphenylhydantoin]. Martiñón Sánchez F; Viso Lorenzo JA An Esp Pediatr; 1990 Jun; 32(6):554-5. PubMed ID: 2221636 [No Abstract] [Full Text] [Related]
38. Randomized controlled study on the use of multiple-dose activated charcoal in patients with supratherapeutic phenytoin levels. Skinner CG; Chang AS; Matthews AS; Reedy SJ; Morgan BW Clin Toxicol (Phila); 2012 Sep; 50(8):764-9. PubMed ID: 22897408 [TBL] [Abstract][Full Text] [Related]
39. [Choreoathetotic movements in a patient with epilepsy after treatment with diphenylhydantoin]. Szczechowski L; Rościszewska D Neurol Neurochir Pol; 1987; 21(3):255-7. PubMed ID: 3118226 [TBL] [Abstract][Full Text] [Related]